We’re Standing Tall against the impact of CLI

On a mission to change the stats—and the status—of CLI amputations

Micro Medical Solutions was formed to do exactly what our name implies—provide solutions to some of the most pressing unmet needs in microvascular intervention.

Our purpose is to give physicians the minimally invasive tools and technology they need to fight the impact of CLI, to significantly reduce the rate of amputations, to improve clinical outcomes and patient quality of life, and to minimize the financial and human costs associated with the treatment of PAD and CLI.

Goals

The goal of better BTK intervention

Micro Medical Solutions has set ambitious goals:

  • We are committed to reduce the number of preventable amputations, thereby reducing the significant morbidity, mortality, and burden of CLI amputations.
  • We’re not just asking important questions in BTK intervention—we’re working on the solutions right now.

Could CLI cases have a different outcome with improved treatment options?

Are we doing everything we can to prevent the cascade that leads to amputations?

How can we look at the problem differently and develop better treatment options?

What if BTK intervention could actually start BTK?

We are dedicating more focus on finding specific solutions for better access to long lesions and CTOs in the peripheral arteries. Developing an innovative pedal access platform with an industry-leading small guide is just one way we are working on the solutions.

See more about our progress here.

Leadership

Visionary leadership and experience

The Micro Medical Solutions leadership team represents a combined 100 years of experience in interventional technology and procedures.

Experience matters, but the ability to develop future BTK solutions matters even more

Greg Sullivan, Founder and CEO, leads the MMS management team. Mr. Sullivan has extensive experience in the Medical Device Industry with over 25 years in the minimally invasive neurology and cardiology market.

Jihad Mustapha, MD, Chief Medical Officer is an interventional cardiologist who specializes in endovascular revascularization of PVD: specifically, CLI. He is the co-founder and CEO of Advanced Cardiac and Vascular Amputation Prevention Centers in Grand Rapids, Michigan. He also serves as Clinical Associate Professor of Medicine at Michigan State University College of Osteopathic Medicine. Dr. Mustapha speaks internationally on the topic of CLI, alternative access, atherectomy, vessel morphology, calcification and drug eluting technology.

Greg Mathison, Vice President of Regulatory Affairs, has more than 35 years of experience in the healthcare industry and has supported the regulatory pathway for 510k approval for more than 200 product submissions to the FDA. He also has been instrumental in the submission of IDE and PMA applications to the FDA, as well as technical dossiers to foreign governments for CE Mark approval.

Tim Robinson, Vice President of Research & Development, has over 26 years of experience in developing minimally invasive products for the medical device industry. He has an extensive background in developing devices for the cardiovascular and neurovascular markets, with a primary focus on stent delivery platforms, balloon-based therapeutic catheters, and steerable sheaths and guiding systems.

Amanda Panos, Vice President of Clinical Affairs, brings over 20 years of experience in the medical device industry with the implementation of pre-clinical, first in man, feasibility, pivotal and post-market clinical studies in the U.S., Europe, Australia, Canada and Latin America to support PMA, 510(k), CE Marking filings and peer review publications.


Scientific Advisory Board

Robert Beasley, MS, MD
Director of Vascular/Interventional
Radiology and Vein Treatment Center
Mt. Sinai Medical Center
Miami Beach, FL

Marianne Brodmann, MD
Professor of Internal Medicine
Division of Angiology
Medical University Graz
Graz, Austria

Thomas Zellar, MD, PhD
Department of Angiology
Clinic Cardiology-AngiologyII
University Heart Center
Freiburg-Bad Krozingen, Germany

Mahmood K. Razavi, MD
Medical Director
Comprehensive Aortic Center
Director, Department of Clinical Trials
St. Joseph Heart & Vascular Center
Orange, CA

Andrej Schmidt, MD
University Hospital of Leipzig
Leipzig, Germany

Craig Walker, MD
Founder, President and Medical Director
Cardiovascular Institute of the South
Houma, LA

Chairman
New Cardiovascular Horizons

Back To Top